Mynaric AG (MYNA)
NASDAQ (NGS) NASDAQ (NGS) Primary 
Pomerantz Law Firm Announces the Filing of a Class Action Against Mynaric AG and Certain Officers – MYNA
NEW YORK, NY / ACCESSWIRE / October 30, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against Mynaric AG ("Mynaric" or the "Company") (NASDAQ:MYNA) and certain officers. The class action, filed in the United States District Court for the Eastern District Of New York, and docketed under 24-cv-07602 is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Mynaric securities between June 20, 2024 and October 7, 2024, both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the "Exchange Act") and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mynaric AG - MYNA
NEW YORK, NY / ACCESSWIRE / October 29, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Mynaric AG ("Mynaric" or the "Company") (NASDAQ:MYNA). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mynaric AG - MYNA
NEW YORK, NY / ACCESSWIRE / October 27, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Mynaric AG ("Mynaric" or the "Company") (NASDAQ:MYNA). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mynaric AG - MYNA
NEW YORK, NY / ACCESSWIRE / October 23, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Mynaric AG ("Mynaric" or the "Company") (NASDAQ:MYNA). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mynaric AG - MYNA
NEW YORK, NY / ACCESSWIRE / October 21, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Mynaric AG ("Mynaric" or the "Company") (NASDAQ:MYNA). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mynaric AG - MYNA
NEW YORK, NY / ACCESSWIRE / October 19, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Mynaric AG ("Mynaric" or the "Company") (NASDAQ:MYNA). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mynaric AG - MYNA
NEW YORK, NY / ACCESSWIRE / October 15, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Mynaric AG ("Mynaric" or the "Company") (NASDAQ:MYNA). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mynaric AG - MYNA
NEW YORK, NY / ACCESSWIRE / October 13, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Mynaric AG ("Mynaric" or the "Company") (NASDAQ:MYNA). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mynaric AG - MYNA
NEW YORK, NY / ACCESSWIRE / October 11, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Mynaric AG ("Mynaric" or the "Company") (NASDAQ:MYNA). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mynaric AG - MYNA
NEW YORK, NY / ACCESSWIRE / October 7, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Mynaric AG ("Mynaric" or the "Company") (NASDAQ:MYNA). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mynaric AG - MYNA
NEW YORK, NY / ACCESSWIRE / October 5, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Mynaric AG ("Mynaric" or the "Company") (NASDAQ:MYNA). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
Mynaric Secures USD 5.5 Million Bridge Loan and Receipt of USD 5.5 Million Manufacturing Readiness Milestone Payment To Meet Immediate Working Capital Needs
MUNICH, GERMANY / ACCESSWIRE / October 2, 2024 / Today, Mynaric AG (NASDAQ:MYNA) (ISIN: US62857X1019) (FRA:M0YN) ISIN: DE000A31C305) (the "Company") entered into an amendment to its existing USD 95 million loan agreement with its U.S.-based lenders, which are funds affiliated with a U.S.-based global investment management firm, pursuant to which the lenders have agreed to provide a bridge loan in the amount of USD 5.5 million. As is the case for the existing USD 95 million term loan agreement, the bridge loan will be guaranteed and secured by the Company and each of its subsidiaries and bear interest at a rate equal to the Term Secured Overnight Financing Rate (SOFR) for a 3-month tenor, subject to a 2% floor, plus a margin of 10% or, at the option of the borrower, a certain alternative base rate, subject to a 2% floor, plus a margin of 9%.
